Abstract CT031: A phase Ib trial to study the safety and tolerability of atezolizumab with radium-223 dichloride in patients with metastatic castrate-resistant prostate cancer (mCRPC)
Year: 2017
Type: conference-abstract
Source: Cancer Research
Institutions: University of California, San Francisco, Memorial Sloan Kettering Cancer Center, Duke University, Duke Cancer Institute, Yale University, Wayne State University, The Barbara Ann Karmanos Cancer Institute, University of Michigan, Sidney Kimmel Cancer Center, Annexon Biosciences (United States), Instacart (United States), Tulane Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2741927315